Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies.

Mofors J, Björk A, Smedby KE, Kvarnström M, Forsblad-d'Elia H, Magnusson-Bucher S, Eriksson P, Mandl T, Baecklund E, Nordmark G, Wahren-Herlenius M.

Ann Rheum Dis. 2019 Nov 6. pii: annrheumdis-2019-216287. doi: 10.1136/annrheumdis-2019-216287. [Epub ahead of print] No abstract available.

PMID:
31694814
2.

Viral antigens elicit augmented immune responses in primary Sjögren's syndrome.

Björk A, Thorlacius GE, Mofors J, Richardsdotter Andersson E, Ivanchenko M, Tingström J, James T, Brokstad KA, Cox RJ, Jonsson R, Kvarnström M, Wahren-Herlenius M.

Rheumatology (Oxford). 2019 Oct 30. pii: kez509. doi: 10.1093/rheumatology/kez509. [Epub ahead of print]

PMID:
31665501
3.

Response to Letter to the Editor by Bartoloni et al: 'Interplay of anti-SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren's syndrome'.

Mofors J, Wahren-Herlenius M, Nordmark G.

J Intern Med. 2019 Oct 20. doi: 10.1111/joim.12996. [Epub ahead of print] No abstract available.

PMID:
31631437
4.

Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: 'Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero' by Satis et al.

Mofors J, Sonesson SE, Wahren-Herlenius M.

Ann Rheum Dis. 2019 Jul 4. pii: annrheumdis-2019-215677. doi: 10.1136/annrheumdis-2019-215677. [Epub ahead of print] No abstract available.

PMID:
31272943
5.

Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.

Mofors J, Holmqvist M, Westermark L, Björk A, Kvarnström M, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Theander E, Mandl T, Wahren-Herlenius M, Nordmark G.

J Intern Med. 2019 Oct;286(4):458-468. doi: 10.1111/joim.12941. Epub 2019 Jun 17.

6.

Infections increase the risk of developing Sjögren's syndrome.

Mofors J, Arkema EV, Björk A, Westermark L, Kvarnström M, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Mandl T, Nordmark G, Wahren-Herlenius M.

J Intern Med. 2019 Jun;285(6):670-680. doi: 10.1111/joim.12888. Epub 2019 Apr 17.

PMID:
30892751
7.

Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero.

Mofors J, Eliasson H, Ambrosi A, Salomonsson S, Skog A, Fored M, Ekbom A, Bergman G, Sonesson SE, Wahren-Herlenius M.

Ann Rheum Dis. 2019 May;78(5):696-703. doi: 10.1136/annrheumdis-2018-214406. Epub 2019 Feb 26.

PMID:
30808622
8.

H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.

Brauner S, Folkersen L, Kvarnström M, Meisgen S, Petersen S, Franzén-Malmros M, Mofors J, Brokstad KA, Klareskog L, Jonsson R, Westerberg LS, Trollmo C, Malmström V, Ambrosi A, Kuchroo VK, Nordmark G, Wahren-Herlenius M.

Ann Rheum Dis. 2017 Oct;76(10):1755-1763. doi: 10.1136/annrheumdis-2016-210509. Epub 2017 Jul 31.

Supplemental Content

Loading ...
Support Center